T Clinics USA logo with the tagline 'Making You Great Again'
T Clinics USA logo with the tagline 'Making You Great Again'
Woman in a robe seated by a window at dusk
Woman in a dark robe seated smiling by a window at dusk

Menopause Hormone Therapy

Provider evaluation · Appropriate testing · Ongoing monitoring

Menopause hormone therapy is prescribed at T Clinics USA in Naples, Fort Myers, and Coral Springs after an in-person evaluation. In February 2026 the FDA removed the boxed warning from menopausal hormone therapy products, revising the labeling behind two decades of caution. Whether it fits you is still an individual clinical question. Results vary by individual.

Menopause hormone therapy is prescribed at T Clinics USA in Naples, Fort Myers, and Coral Springs after an in-person evaluation. In February 2026 the FDA removed the boxed warning from menopausal hormone therapy products, revising the labeling behind two decades of caution. Whether it fits you is still an individual clinical question. Results vary by individual.

  • FEB 2026 LABELING CHANGE

  • ESTRADIOL & PROGESTERONE

  • ROUTE MATTERS

  • FDA-APPROVED FORMULATIONS

  • FEB 2026 LABELING CHANGE

  • ESTRADIOL & PROGESTERONE

  • ROUTE MATTERS

  • FDA-APPROVED FORMULATIONS

  • FEB 2026 LABELING CHANGE

  • ESTRADIOL & PROGESTERONE

  • ROUTE MATTERS

  • FDA-APPROVED FORMULATIONS

TWO STEPS TO A FREE CONSULTATION

The signs are easy to dismiss. The cause is worth checking.

These are common experiences people bring to us. Two steps, about a minute, and a licensed provider's team takes it from there. Only a provider and lab work can determine what's behind them.

Step 1 of 2

Check off what sounds familiar

Tap every item below that applies to you. Tap it again to unselect. Check off as many as you like, or none at all.

Step 2 of 2

Fill out the booking form

Add your contact details below and a licensed provider's team will reach out to confirm your free consultation. Whatever you checked off in step 1 is included with your request.

From step 1: what you checked off

You have not checked off any items yet. You can still request a consultation.

These items go to the care team so your consultation starts with context. They are not a diagnosis or an assessment.

Include area code, for example 239 555 0134.

This is general information, not a medical assessment or diagnosis. A licensed provider determines whether any condition is present and whether treatment is appropriate. Results vary by individual.

0 items checked off

TWO STEPS TO A FREE CONSULTATION

The signs are easy to dismiss. The cause is worth checking.

These are common experiences people bring to us. Two steps, about a minute, and a licensed provider's team takes it from there. Only a provider and lab work can determine what's behind them.

Step 1 of 2

Check off what sounds familiar

Tap every item below that applies to you. Tap it again to unselect. Check off as many as you like, or none at all.

Step 2 of 2

Fill out the booking form

Add your contact details below and a licensed provider's team will reach out to confirm your free consultation. Whatever you checked off in step 1 is included with your request.

From step 1: what you checked off

You have not checked off any items yet. You can still request a consultation.

These items go to the care team so your consultation starts with context. They are not a diagnosis or an assessment.

Include area code, for example 239 555 0134.

This is general information, not a medical assessment or diagnosis. A licensed provider determines whether any condition is present and whether treatment is appropriate. Results vary by individual.

0 items checked off

The Warning That Shaped Twenty Years Of Advice Was Removed

In November 2025 HHS and the FDA announced removal of the boxed warnings on menopausal hormone therapy, and the labeling change took effect in February 2026. The FDA approved changes to six menopausal hormone therapy products, deleting the risk statements on cardiovascular disease, breast cancer and probable dementia from the boxed warning. One warning remains: the boxed warning for endometrial cancer on systemic estrogen-alone products was not removed. That labeling shaped how a generation of women were advised. If you raised this with a doctor in 2008 and were told the risks ruled it out, the basis for that advice has since been revised. It does not mean hormone therapy is right for everyone. It means the conversation is worth having again. Roughly 1.3 million women in the United States enter menopause each year, and by most estimates fewer than 2% receive adequate treatment. At T Clinics USA in Naples, Fort Myers, and Coral Springs, that conversation happens in person, with a provider who has your history and your labs, in a practice that treats both men and women. Results vary by individual.

T Clinics USA monogram logo on a dark background
T Clinics USA monogram logo on a dark background

FDA labeling change February 2026 · Endometrial warning retained · FDA-approved formulations · In-person evaluation

What Changed, And What Did Not

In February 2026 the FDA removed the boxed warning from menopausal hormone therapy products, deleting the risk statements on cardiovascular disease, breast cancer and probable dementia. The boxed warning for endometrial cancer on systemic estrogen-alone products remains, which is why progesterone is included when a uterus is present. Removal of a warning is not a recommendation. It means the labeling that discouraged a generation of women has been revised, and the decision returns to where it belonged: an individual evaluation of your history, your risk factors and your symptoms, made with a provider who has both in front of them.

What Changed, And What Did Not

In February 2026 the FDA removed the boxed warning from menopausal hormone therapy products, deleting the risk statements on cardiovascular disease, breast cancer and probable dementia. The boxed warning for endometrial cancer on systemic estrogen-alone products remains, which is why progesterone is included when a uterus is present. Removal of a warning is not a recommendation. It means the labeling that discouraged a generation of women has been revised, and the decision returns to where it belonged: an individual evaluation of your history, your risk factors and your symptoms, made with a provider who has both in front of them.

A Conversation Worth Reopening

Menopause hormone therapy at T Clinics USA is prescribed after an in-person evaluation at one of three Florida clinics.

February 2026

The FDA labeling change removing the boxed warning from menopausal hormone therapy products took effect.

February 2026

The FDA labeling change removing the boxed warning from menopausal hormone therapy products took effect.

6 products

The FDA approved labeling changes on six menopausal hormone therapy products, deleting three risk statements.

6 products

The FDA approved labeling changes on six menopausal hormone therapy products, deleting three risk statements.

FDA-approved

Regimens are built from approved formulations rather than compounded preparations marketed as more natural.

FDA-approved

Regimens are built from approved formulations rather than compounded preparations marketed as more natural.

How It Works

How A Hormone Therapy Regimen Is Built

Hands at a table with a supplement bottle and a dish

01

ESTRADIOL AND WHY PROGESTERONE IS INCLUDED

The components are selected for your anatomy and history, not chosen from a menu.

Estradiol addresses the symptoms driven by declining estrogen. Progesterone is included when you still have a uterus, because systemic estrogen without it carries endometrial risk. That is also why the FDA left the endometrial cancer boxed warning in place on estrogen-alone products. Your provider determines the combination from your clinical picture.

Hands at a table with a supplement bottle and a dish

01

ESTRADIOL AND WHY PROGESTERONE IS INCLUDED

The components are selected for your anatomy and history, not chosen from a menu.

Estradiol addresses the symptoms driven by declining estrogen. Progesterone is included when you still have a uterus, because systemic estrogen without it carries endometrial risk. That is also why the FDA left the endometrial cancer boxed warning in place on estrogen-alone products. Your provider determines the combination from your clinical picture.

Transdermal patch on a bare shoulder beside a glass of water and pills

02

TRANSDERMAL VERSUS ORAL

Delivery route is a clinical decision with different risk profiles.

Oral and transdermal estrogen do not behave identically in the body, and the difference matters for certain histories. Your provider reviews your cardiovascular and clotting history, your other medications and your preferences before selecting a route. This is one of several decisions that a questionnaire-based platform makes by protocol rather than by patient.

Transdermal patch on a bare shoulder beside a glass of water and pills

02

TRANSDERMAL VERSUS ORAL

Delivery route is a clinical decision with different risk profiles.

Oral and transdermal estrogen do not behave identically in the body, and the difference matters for certain histories. Your provider reviews your cardiovascular and clotting history, your other medications and your preferences before selecting a route. This is one of several decisions that a questionnaire-based platform makes by protocol rather than by patient.

Amber bottle, tube, sachet and blister pack of pills on a dark tray

03

CHOSEN FOR RESULTS, NOT LABELS

Where an approved product exists, that is what gets prescribed.

ACOG has cautioned that compounded preparations are marketed with claims of being more natural or safer than FDA-approved products, that evidence for those claims is lacking, and that compounded therapy should not be prescribed routinely when approved formulations exist. Several direct-to-consumer platforms are built around compounded products. T Clinics prescribes FDA-approved formulations, and the reasoning is available to you.

Amber bottle, tube, sachet and blister pack of pills on a dark tray

03

CHOSEN FOR RESULTS, NOT LABELS

Where an approved product exists, that is what gets prescribed.

ACOG has cautioned that compounded preparations are marketed with claims of being more natural or safer than FDA-approved products, that evidence for those claims is lacking, and that compounded therapy should not be prescribed routinely when approved formulations exist. Several direct-to-consumer platforms are built around compounded products. T Clinics prescribes FDA-approved formulations, and the reasoning is available to you.

You have questions, we have answers.

Did the FDA remove the warning on hormone therapy?

Did the FDA remove the warning on hormone therapy?

Is hormone therapy safe now?

Is hormone therapy safe now?

Do I need progesterone with estrogen?

Do I need progesterone with estrogen?

Is a patch better than a pill?

Is a patch better than a pill?

What about bioidentical hormones?

What about bioidentical hormones?

I was told years ago I could not take hormone therapy. Has that changed?

I was told years ago I could not take hormone therapy. Has that changed?

See What Fits Your Goals